Catalyst Pharmaceuticals Inc (CPRX) — Capital Reinvestment Ratio
Catalyst Pharmaceuticals Inc (CPRX) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($44.89 Million) in capital expenditures ($32.00K). See debt-free asset ratio of Catalyst Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Catalyst Pharmaceuticals Inc Capital Reinvestment Ratio (2019–2025)
This chart tracks Catalyst Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods. Check cash flow reinvestment rate of Catalyst Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year Capital Reinvestment Ratio for Catalyst Pharmaceuticals Inc from 2019 to 2025. For live market cap and broader valuation context, see Catalyst Pharmaceuticals Inc (CPRX) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $208.67 Million | $58.00K | ▼ -88.0% |
| 2024 | 0.00x | $239.81 Million | $556.00K | ▼ -99.6% |
| 2023 | 0.57x | $143.60 Million | $81.74 Million | ▲ +227691.4% |
| 2022 | 0.00x | $116.05 Million | $29.00K | ▼ -98.5% |
| 2021 | 0.02x | $60.37 Million | $1.02 Million | ▲ +6584.4% |
| 2020 | 0.00x | $45.03 Million | $11.39K | ▼ -54.8% |
| 2019 | 0.00x | $34.61 Million | $19.37K | — |